Aldesleukin Recruiting Phase 1 Trials for Melanoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01946373T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma